Cargando…

Whole-Genome Analysis of Acinetobacter baumannii Strain AB43 Containing a Type I-Fb CRISPR-Cas System: Insights into the Relationship with Drug Resistance

The CRISPR-Cas system is a bacterial and archaea adaptive immune system and is a newly recognized mechanism for controlling antibiotic resistance gene transfer. Acinetobacter baumannii (A. baumannii) is an important organism responsible for a variety of nosocomial infections. A. baumannii infections...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Tingting, Yang, Jie, Sun, Xiaoli, Wang, Yuhang, Yang, Liying, Kong, Guimei, Jiao, Hongmei, Bao, Guangyu, Li, Guocai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458022/ https://www.ncbi.nlm.nih.gov/pubmed/36080431 http://dx.doi.org/10.3390/molecules27175665

Ejemplares similares

CRISPR-Cas in Acinetobacter baumannii Contributes to Antibiotic Susceptibility by Targeting Endogenous AbaI
por: Wang, Yuhang, et al.
Publicado: (2022)

Synergistic Activity of Capsaicin and Colistin Against Colistin-Resistant Acinetobacter baumannii: In Vitro/Vivo Efficacy and Mode of Action
por: Guo, Tingting, et al.
Publicado: (2021)

The Involvement of the csy1 Gene in the Antimicrobial Resistance of Acinetobacter baumannii
por: Guo, Tingting, et al.
Publicado: (2022)

Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro
por: Guo, Tingting, et al.
Publicado: (2022)

CRISPR-cas Subtype I-Fb in Acinetobacter baumannii: Evolution and Utilization for Strain Subtyping
por: Karah, Nabil, et al.
Publicado: (2015)

Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075
por: Anderson, Sarah E., et al.
Publicado: (2018)

CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in Acinetobacter baumannii
por: Wang, Yu, et al.
Publicado: (2020)

Isolation and Characterization of a Virulent Bacteriophage AB1 of Acinetobacter baumannii
por: Yang, Hongjiang, et al.
Publicado: (2010)

Analysis of CRISPR/Cas Genetic Structure, Spacer Content and Molecular Epidemiology in Brazilian Acinetobacter baumannii Clinical Isolates
por: Silva, Adrianne M. A., et al.
Publicado: (2023)

Characterization of Extremely Drug-Resistant and Hypervirulent Acinetobacter baumannii AB030
por: Singh, Manu, et al.
Publicado: (2020)

Genomic and Phenotypic Analysis of Multidrug-Resistant Acinetobacter baumannii Clinical Isolates Carrying Different Types of CRISPR/Cas Systems
por: Tyumentseva, Marina, et al.
Publicado: (2021)

Draft Genome Sequence of the Mercury-Resistant Strain Acinetobacter baumannii I43
por: de Siqueira, Kátia Aparecida, et al.
Publicado: (2018)

In vitro and in vivo Virulence Potential of the Emergent Species of the Acinetobacter baumannii (Ab) Group
por: Cosgaya, Clara, et al.
Publicado: (2019)

CRISPR-Based Gene Editing in Acinetobacter baumannii to Combat Antimicrobial Resistance
por: Junaid, Muhammad, et al.
Publicado: (2023)

Structural basis for fragmenting the exopolysaccharide of Acinetobacter baumannii by bacteriophage ΦAB6 tailspike protein
por: Lee, I-Ming, et al.
Publicado: (2017)

Occurrence of Acinetobacter baumannii genomic resistance islands (AbGRIs) in Acinetobacter baumannii strains belonging to global clone 2 obtained from COVID-19 patients
por: Naderi, Ghazal, et al.
Publicado: (2023)

Subunit vaccines for Acinetobacter baumannii
por: Yang, Ning, et al.
Publicado: (2023)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

A pyrF-Based Efficient Genetic Manipulation Platform in Acinetobacter baumannii To Explore the Vital DNA Components of Adaptive Immunity for I-F CRISPR-Cas
por: Wu, Shuqi, et al.
Publicado: (2022)

Genome Sequence of an Extremely Drug-Resistant Clinical Isolate of Acinetobacter baumannii Strain AB030
por: Loewen, Peter C., et al.
Publicado: (2014)

Multiple roles for a novel RND‐type efflux system in Acinetobacter baumannii AB5075
por: Tipton, Kyle A., et al.
Publicado: (2016)

Phage φAB6-Borne Depolymerase Combats Acinetobacter baumannii Biofilm Formation and Infection
por: Shahed-Al-Mahmud, Md., et al.
Publicado: (2021)

MacAB-TolC Contributes to the Development of Acinetobacter baumannii Biofilm at the Solid–Liquid Interface
por: Robin, Brandon, et al.
Publicado: (2022)

The Acinetobacter baumannii website (Ab-web): a multidisciplinary knowledge hub, communication platform, and workspace
por: Karah, Nabil, et al.
Publicado: (2023)

Variants of AbGRI3 carrying the armA gene in extensively antibiotic-resistant Acinetobacter baumannii from Singapore
por: Blackwell, Grace A., et al.
Publicado: (2017)

Potential of bacteriophage ΦAB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii
por: Chen, Li-Kuang, et al.
Publicado: (2013)

Relationship between Tolerance and Persistence Mechanisms in Acinetobacter baumannii Strains with AbkAB Toxin-Antitoxin System
por: Fernández-García, Laura, et al.
Publicado: (2018)

Insights into the Periplasmic Proteins of Acinetobacter baumannii AB5075 and the Impact of Imipenem Exposure: A Proteomic Approach
por: Scribano, Daniela, et al.
Publicado: (2019)

Isolation and Characterization of AbTJ, an Acinetobacter baumannii Phage, and Functional Identification of Its Receptor-Binding Modules
por: Xu, Jingzhi, et al.
Publicado: (2020)

Total Syntheses of Conjugation‐Ready Repeating Units of Acinetobacter baumannii AB5075 for Glycoconjugate Vaccine Development
por: Zhang, Shuo, et al.
Publicado: (2021)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Diagnosis of Acinetobacter Baumannii Infections
por: Gozdas, Hasan T
Publicado: (2012)

Acinetobacter baumannii—The New MRSA?
por: Barrie, Alasdair, et al.
Publicado: (2016)

Glycosphingolipids Recognized by Acinetobacter baumannii
por: Madar Johansson, Miralda, et al.
Publicado: (2020)

Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii
por: Kuo, Shu-Chen, et al.
Publicado: (2015)

Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China
por: Zhao, Yongxin, et al.
Publicado: (2019)

Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2
por: Peng, Shih-Yi, et al.
Publicado: (2017)

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
por: Yang, Ya-Sung, et al.
Publicado: (2013)

Risk Factors and Clinical Outcomes for Patients With Acinetobacter baumannii Bacteremia
por: Gu, Zhenyang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0c3h8h7nd0ouor98o3pa8qlqdr